0000899243-21-015323.txt : 20210407
0000899243-21-015323.hdr.sgml : 20210407
20210407183410
ACCESSION NUMBER: 0000899243-21-015323
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210405
FILED AS OF DATE: 20210407
DATE AS OF CHANGE: 20210407
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Carey John F
CENTRAL INDEX KEY: 0001774272
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38891
FILM NUMBER: 21813347
MAIL ADDRESS:
STREET 1: 200 MINUTEMAN ROAD
STREET 2: SUITE 302
CITY: ANDOVER
STATE: MA
ZIP: 01810
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TransMedics Group, Inc.
CENTRAL INDEX KEY: 0001756262
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 000000000
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 MINUTEMAN ROAD
CITY: ANDOVER
STATE: MA
ZIP: 01810
BUSINESS PHONE: 9785520900
MAIL ADDRESS:
STREET 1: 200 MINUTEMAN ROAD
CITY: ANDOVER
STATE: MA
ZIP: 01810
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-04-05
0
0001756262
TransMedics Group, Inc.
TMDX
0001774272
Carey John F
C/O TRANSMEDICS GROUP, INC.
200 MINUTEMAN ROAD
ANDOVER
MA
01810
0
1
0
0
VP of Operations
Common Stock
2021-04-05
4
M
0
3360
16.14
A
3360
D
Common Stock
2021-04-05
4
S
0
760
34.43
D
2600
D
Common Stock
2021-04-05
4
S
0
800
35.99
D
1800
D
Common Stock
2021-04-05
4
S
0
1000
37.62
D
800
D
Common Stock
2021-04-05
4
S
0
600
38.68
D
200
D
Common Stock
2021-04-05
4
S
0
200
40.48
D
0
D
Stock Option (Right to Buy)
16.14
2021-04-05
4
M
0
3360
0.00
D
2030-02-27
Common Stock
3360
11640
D
The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $34.17 to $34.78, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $35.50 to $36.48, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $37.01 to $38.00, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $38.09 to $39.08, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $40.28 to $40.67, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020.
/s/ Stephen Gordon, Attorney-in-Fact
2021-04-06